Drawing for ISOHUB

USPTO serial 79307280

ISOHUB

Reviewed by CopyMark Law Group

Reg. 6891260Status 700Registered
Filing date
Status date
Registration date
Nov 8, 2022
Examiner
I, DAVID C
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ISOHUB?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bradley M. Stohry

Bradley M. Stohry Reichel Stohry Dean LLP525 S. Meridian St., Suite 1A2Indianapolis, IN 46225UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Scientific research and laboratory apparatus and instruments, namely, automated laboratory robots for sensing, detecting, viewing, visualising, imaging, counting, measuring, identifying, investigating, analysing, testing particles, dead and live cells and organoids, confirming cell monoclonality microscopically, microscopically and chemically testing and identifying cell colonies derived from single cells, performing downstream bioassays, recording and transferring biological data and image relating to the culture of cells; Laboratory equipment, namely, a laboratory benchtop systems comprised of electronic imaging apparatus, microscopes, cameras, chemical and electronic analyzers, electronic circuit boards, electronic control circuits, data processing equipment, wireless apparatus for the transfer of data and image, and recorded operating system software for sensing, detecting, viewing, visualising, imaging, counting, measuring, identifying, analysing, testing organoids, dead or live cells or other particles, and recording image and data; Laboratory equipment, namely, benchtop systems comprised of bioimaging systems, chemical and electronic analyzers, printed circuit boards, electronic control circuits, data recorders, data processers, wireless data-transfer system, and recorded operating software for automating micro-biology workflows for particles, cell and organoid culture in microfluidic devices; Laboratory equipment, namely, imaging systems comprised of microscopes, cameras, an illumination source, printed and electronic circuit boards, a user interface, recorded and downloadable operating system software and electronic and chemical analyzers that assay DNA, RNA, protein, fats, and metabolites in samples collected from the microfluidic devices in order to assess the genetic and metabolic state of cells and organoids; Laboratory instruments for scientific use, namely, diagnostic apparatus, not for medical purposes, for use in viewing, imaging, investigating and analyzing biological, chemical, biochemical, bacteriological material including DNA, RNA, proteins and small molecules; Downloadable and recorded software for use in the automation of laboratories in the fields of micro-fluids, biology, life sciences, namely, software for use in automating workflows, providing users with records of processes, capturing, recording and transmitting images and data for analysis, and facilitating and automating single-cell isolation, cloning and harvesting; Downloadable and recorded computer aided manufacturing (CAM) software for micro-biology applications and micro-fluidic applications, namely, for culturing particles, cells and organoids as they grow in microfluidic arrangements or devices, and for performing bioassays on the live/dead particles, cells, organoids and liquids in the micro-fluidic arrangements or devices; data processing apparatus; data storage apparatus and devices, namely, high-speed storage subsystems for storage and backup of electronic data either locally or via a telecommunications network; data storage programs, namely, recorded or downloadable computer programs for use in electronic storage of data; data transmitters, namely, wireless transmission, ethernet cables for data transmission, and SD card for data transport; data capture apparatus, namely, touch-screen or joystick apparatus for use to capture images from a camera attached to a microscope; apparatus for recording data, namely, computer hard disk, memory drive; optical data recording media, namely, blank optical discs; optical data storage drives, namely, optical disk drives; optical data carriers being recorded software for micro-biology applications and micro-fluidic applications, namely, for culturing particles, cells and organoids as they grow in microfluidic arrangements or devices, and for performing bioassays on the live/dead particles, cells, organoids and liquids in the arrangements or devices; Laboratory equipment in the nature of image scanning apparatus, instruments and equipment, namely, electronic camera attached to a microscope for image or video capturing of particles, and live or dead cells or organoids growing in the microfluidic arrangements or devices; image processing apparatus, instruments and equipment for recording, transmission, processing and reproduction of sound, images or data; Imaging apparatus and devices for scientific purposes, namely, imaging systems comprised of microscopes, cameras, illumination sources, printed circuit boards, electronic control circuits, a user interface and recorded operating system software for use in obtaining, storing, recording, processing, transmitting, reproducing, examining, investigating, analysing and/or processing images of organoids, cells, and particles; Imaging apparatus and devices for scientific purposes, namely, instruments for use in the preparation and culture of cells, namely, single cell isolation, verification of monoclonality, verification of growth, testing and analysis of particles, live and dead cells and organoids; Image scanners for capturing images for analysis and use in the life science research field and particles, live and dead cells and organoids; Image analysers, namely, scanners for capturing images for analysis and use in the life science research field and particles, live and dead cells and organoidsACTIVE—
010Medical apparatus and instruments for diagnostic use, namely, apparatus and instruments incorporating image recorders, analyzers and supporting downloadable and recorded software, for medical diagnostic testing for detecting cancer and other tissue-based ailments and diseases; Medical diagnostic apparatus for medical cell sampling to be used for viewing, imaging, investigating, analyzing and recording biological, chemical, biochemical, bacteriological material including DNA, RNA, proteins and small molecules for diagnosing, identifying and detecting cancer, and other tissue-based ailments and diseases; Medical diagnostic instruments and apparatus that integrate and automate downstream assays applied to particles, cells and organoids growing in microfluidic devices, namely, imaging systems comprised of microscopes, cameras, illumination sources, printed circuit boards, electronic control circuits, user interface operating system and downloadable and recorded software, and electronic and chemical analyzers that assay DNA, RNA, protein, fats, and metabolites in samples collected from the microfluidic devices in order to assess the genetic and metabolic state of cells and organoids for diagnosing, identifying and detecting cancer, and other tissue-based ailments and diseases; Medical device used for viewing, imaging, recording, investigating and analyzing biological, chemical, biochemical, bacteriological material including DNA, RNA, proteins and small molecules for diagnosing, identifying and detecting cancer, and other tissue-based ailments and diseases; Apparatus for analysing images for medical purposes, namely, imaging systems comprised of microscopes, cameras, illumination sources, printed circuit boards, electronic control circuits, user interface operating system downloadable and recorded software for use in obtaining, storing, recording, processing, transmitting, reproducing, examining, investigating, analysing and processing images of organoids, cells, and particles; medical imaging apparatus for diagnosing, identifying and detecting cancer, and other tissue-based ailments and diseases; diagnostic imaging apparatus for medical use, namely, imaging apparatus and instruments for use in the preparation and culture of cells, namely, single cell isolation, verification of monoclonality, verification of growth, testing and analysis of particles, live and dead cells and organoids for diagnosing, identifying and detecting cancer, and other tissue-based ailments and diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 21, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 1, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 1, 2023FIMPFINAL DISPOSITION PROCESSED—
Feb 8, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 8, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 8, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 20, 2022OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Sep 5, 2022GPNXNOTIFICATION PROCESSED BY IB—
Aug 31, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 31, 2022OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Aug 23, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 23, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 3, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 3, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Aug 3, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 20, 2022PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 19, 2022ALIEASSIGNED TO LIE—
Jul 12, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 12, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Jul 12, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 12, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 12, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
May 2, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 2, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 2, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 5, 2022ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Mar 22, 2022PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Mar 4, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 4, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 4, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 4, 2022ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Dec 11, 2021GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Dec 11, 2021GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 11, 2021CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 18, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 18, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 18, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 24, 2021RFNTREFUSAL PROCESSED BY IB—
Apr 30, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 30, 2021RFRRREFUSAL PROCESSED BY MPU—
Apr 27, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 26, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 7, 2021DOCKASSIGNED TO EXAMINER—
Apr 2, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 29, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 25, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance